Get the tools used by (smart)2 investors.

Downside (Analyst Target) for Pfizer Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PFE *: Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various...

513.28 MXN
Price
MXN
Fair Value
Upside
429.00 - 597.50
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Pfizer Inc's Downside (Analyst Target):

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024

Performance Summary
  • Downside (analyst target) for Pfizer is not available.

How does Pfizer's Downside (Analyst Target) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Pfizer Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Downside (Analyst Target)

Hide this widget
analyst_target_downside
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Downside (Analyst Target) in the predictions category include:

View Full List

Search for metric or datapoint

Downside (Analyst Target)

The percentage decrease (if positive) or increase (if negative) that professional analysts expect over the current stock price.

Definition of Downside (Analyst Target)

Hide this widget

Downside (Analyst Target) is the percentage decrease (if positive) or increase (if negative) that professional analysts expect over the current stock price. This is the inverse of Upside (Analyst Target)

Downside = (Analyst Price Target / Stock Price - 1) * -1

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-513.6%-313.6%-113.6%114.0%050100150200

The chart above depicts the distribution of downside (analyst target) for companies operating in the Healthcare sector in the Developed economic region. Over 3,175 companies were considered in this analysis, and 1,784 had meaningful values. The average downside (analyst target) of companies in the sector is -110.4% with a standard deviation of 118.1%.

Pfizer Inc's Downside (Analyst Target) of NA ranks in the - percentile for the sector. The following table provides additional summary stats:

Downside (Analyst Target) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents3,180
Included Constituents1,784
Min-498.6%
Max99.0%
Median-70.9%
Mean-110.4%
Standard Deviation118.1%

You can find companies with similar downside (analyst target) using this stock screener.

All rights reserved. Terms Of Use